The American Academy of Pediatrics Subcommittee on Bronchiolitis has published a new clinical practice guideline on diagnosing and managing bronchiolitis in infants aged 1 to 23 months.
The American Academy of Pediatrics (AAP) Subcommittee on Bronchiolitis has published a new clinical practice guideline on diagnosing and managing bronchiolitis in infants aged 1 to 23 months. The new guidelines update the 2006 version and are based on a review of the evidence published since the original evidence review in 2004.
Diagnostic guidelines for bronchiolitis recommend that physicians base diagnosis on history and physical examination and avoid routinely ordering radiographic or laboratory studies. Doctors also need to consider risk factors for severe disease-including age younger than 12 weeks, prematurity, underlying cardiopulmonary disease, and immunodeficiency-when making evaluation and management decisions.
Regarding treatment, the AAP recommends against administering albuterol (or salbutamol), epinephrine, or systemic corticosteroids to infants and children with bronchiolitis. Clinicians should give antibiotics only when the patient has, or is strongly suspected to have, a concurrent bacterial infection. Nebulized hypertonic saline shouldn’t be administered in the emergency department, but it may be given to hospitalized infants and children. Children who can’t sustain oral hydration should receive nasogastric or intravenous fluids. Physicians shouldn’t use chest physiotherapy on infants and children with bronchiolitis.
Peer-reviewed: An essential update of cystic fibrosis
For preventing bronchiolitis, the guidelines recommend against giving palivizumab to otherwise healthy infants of gestational age 29 weeks or older, but endorse giving the drug during the first year of life to infants with hemodynamically significant heart disease or chronic lung disease associated with prematurity (preterm infants aged younger than 32 days who require more than 21% oxygen for at least the first 28 days of life). Infants who qualify for palivizumab in their first year should receive a maximum of 5 monthly doses (15 mg/kg/dose) during respiratory syncytial virus season.
All caregivers of infants with bronchiolitis should disinfect their hands with alcohol-based rubs (preferably) or soap and water before and after direct contact with the patient or inanimate objects in the immediate vicinity and after removing gloves.
When assessing for bronchiolitis, clinicians should ask about exposure to tobacco smoke and counsel caregivers about preventing exposure and undertaking smoking cessation. They should also encourage exclusive breastfeeding for at least 6 months to minimize the effects of respiratory infection and educate families about diagnosis, treatment, and prevention of bronchiolitis.
To get weekly clinical advice for today's pediatrician, subscribe to the Contemporary Pediatrics PediaMedia.
Stress ulcer prophylaxis does not provide prevention of gastrointestinal bleeding in neonates
December 4th 2023In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
Preterm infant HRQOL: Long-term impacts and determinants
October 21st 2023A recent study was highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition that shed light on the long-term impact of very preterm birth on the health-related quality of life (HRQOL) of infants and identified key determinants.
Associations between prenatal metal mixture exposure and negative infant outcomes
September 19th 2023Francheska M. Merced-Nieves, PhD, Assistant professor, Departments of Pediatrics and the Institute for Exposomic Research of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, explains the associations prenatal exposure to a metal mixture and the potential negative effects for the infant.